Grant M - Search Results

1

Outcome of donor-derived TAA-T cell therapy in patients with high-risk or relapsed acute leukemia post allogeneic BMT.

Kinoshita H, Cooke KR, Grant M, Stanojevic M, Cruz CR, Keller M, Fortiz MF, Hoq F, Lang H, Barrett AJ, Liang H, Tanna J, Zhang N, Shibli A, Datar A, Fulton K, Kukadiya D, Zhang A, Williams KM, Dave H, Dome JS, Jacobsohn D, Hanley PJ, Jones RJ, Bollard CM. Kinoshita H, et al. Among authors: grant m. Blood Adv. 2022 Apr 26;6(8):2520-2534. doi: 10.1182/bloodadvances.2021006831. Blood Adv. 2022. PMID: 35244681 Free PMC article. Clinical Trial.

2

Cell therapies for hematological malignancies: don't forget non-gene-modified t cells!

Grant ML, Bollard CM. Grant ML, et al. Blood Rev. 2018 May;32(3):203-224. doi: 10.1016/j.blre.2017.11.004. Epub 2017 Nov 27. Blood Rev. 2018. PMID: 29198753 Free PMC article. Review.

3

Developing T-cell therapies for lymphoma without receptor engineering.

Grant M, Bollard CM. Grant M, et al. Hematology Am Soc Hematol Educ Program. 2017 Dec 8;2017(1):622-631. doi: 10.1182/asheducation-2017.1.622. Hematology Am Soc Hematol Educ Program. 2017. PMID: 29222313 Free PMC article. Review.

4

Developing T-cell therapies for lymphoma without receptor engineering.

Grant M, Bollard CM. Grant M, et al. Blood Adv. 2017 Dec 8;1(26):2579-2590. doi: 10.1182/bloodadvances.2017009886. eCollection 2017 Dec 12. Blood Adv. 2017. PMID: 29296911 Free PMC article. Review.

5

Mycobacteria-Specific T Cells May Be Expanded From Healthy Donors and Are Near Absent in Primary Immunodeficiency Disorders.

Patel S, Lang H, Sani G, Freeman AF, Leiding J, Hanley PJ, Cruz CR, Grant M, Wang Y, Oshrine B, Palmer C, Holland SM, Bollard CM, Keller MD. Patel S, et al. Among authors: grant m. Front Immunol. 2019 Mar 29;10:621. doi: 10.3389/fimmu.2019.00621. eCollection 2019. Front Immunol. 2019. PMID: 30984189 Free PMC article.

6

HIV-Specific T Cells Can Be Generated against Non-escaped T Cell Epitopes with a GMP-Compliant Manufacturing Platform.

Patel S, Hanajiri R, Grant M, Saunders D, Van Pelt S, Keller M, Hanley PJ, Simon G, Nixon DF, Hardy D, Jones RB, Bollard CM. Patel S, et al. Among authors: grant m. Mol Ther Methods Clin Dev. 2019 Oct 11;16:11-20. doi: 10.1016/j.omtm.2019.10.001. eCollection 2020 Mar 13. Mol Ther Methods Clin Dev. 2019. PMID: 31720305 Free PMC article.

7

T-Cell Therapeutics Targeting Human Parainfluenza Virus 3 Are Broadly Epitope Specific and Are Cross Reactive With Human Parainfluenza Virus 1.

Harris KM, Horn SE, Grant ML, Lang H, Sani G, Jensen-Wachspress MA, Kankate VV, Datar A, Lazarski CA, Bollard CM, Keller MD. Harris KM, et al. Among authors: grant ml. Front Immunol. 2020 Oct 5;11:575977. doi: 10.3389/fimmu.2020.575977. eCollection 2020. Front Immunol. 2020. PMID: 33123159 Free PMC article.

8

Identification of novel HLA-restricted preferentially expressed antigen in melanoma peptides to facilitate off-the-shelf tumor-associated antigen-specific T-cell therapies.

Stanojevic M, Hont AB, Geiger A, O'Brien S, Ulrey R, Grant M, Datar A, Lee PH, Lang H, Cruz CRY, Hanley PJ, Barrett AJ, Keller MD, Bollard CM. Stanojevic M, et al. Among authors: grant m. Cytotherapy. 2021 Aug;23(8):694-703. doi: 10.1016/j.jcyt.2021.03.001. Epub 2021 Apr 5. Cytotherapy. 2021. PMID: 33832817 Free PMC article.

9

Tumor-associated antigen-specific T cells with nivolumab are safe and persist in vivo in relapsed/refractory Hodgkin lymphoma.

Dave H, Terpilowski M, Mai M, Toner K, Grant M, Stanojevic M, Lazarski C, Shibli A, Bien SA, Maglo P, Hoq F, Schore R, Glenn M, Hu B, Hanley PJ, Ambinder R, Bollard CM. Dave H, et al. Among authors: grant m. Blood Adv. 2022 Jan 25;6(2):473-485. doi: 10.1182/bloodadvances.2021005343. Blood Adv. 2022. PMID: 34495306 Free PMC article. Clinical Trial.

10

Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors.

Rivero-Hinojosa S, Grant M, Panigrahi A, Zhang H, Caisova V, Bollard CM, Rood BR. Rivero-Hinojosa S, et al. Among authors: grant m. Nat Commun. 2021 Nov 18;12(1):6689. doi: 10.1038/s41467-021-26936-y. Nat Commun. 2021. PMID: 34795224 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,699 results

Search Page